Skip to content

Study on the effect and mechanism of three-circle post standing qigong on overweight population based on the theory of

Study on the effect and mechanism of three-circle post standing qigong on overweight population based on the theory of

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006701
Enrollment
Unknown
Registered
2022-10-12
Start date
2022-10-12
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight

Interventions

Standing group:Three circle post standing qigong

Sponsors

Chengdu Sport University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Aged 18 to 45 years; (2) diagnose as overweight; (3) voluntarily participate in this research and be able to provide the written informed consent form for participation in the trial and take part in TCPSQ training on time

Exclusion criteria

Exclusion criteria: (1) secondary overweight due to other disease or oral medication. (2) Being or having been engaged in a long-term regular practice of PSQ or other forms of Qigong or athletic sports; (3) History of dizziness fall or lose consciousness; (4) Those who are not suitable for exercise training due to diseases of the muscle or skeletal system or other contraindications to exercise; (5) History of drug abuse, family history of psychosis, stress disorder, personality disorder and psychoactive substance user. (6) pregnancy and lactation (7) Those who have suffered from malignant tumor, severe consumptive disease, cerebrovascular disease, communicable disease, mental illness, and severe cardiovascular, liver, kidney, gastrointestinal and hematological diseases, musculoskeletal system diseases, or other contraindication to mild to moderate-physical exertion; (8) Those who had taken weight-loss related medications or functional foods within 8 weeks before the start of the study; (9) Those who have participated in or are participating in other clinical trials that affect the evaluation of the results of this study within 8 weeks before the start of this study; (10) Those who inability to comprehend and complete the study assessments or comply with the study instructions.

Design outcomes

Primary

MeasureTime frame
body fat rate;Blood lipid;fasting plasma glucose test;BMI;glycosylated hemoglobin;

Secondary

MeasureTime frame
SF-36 health scale;

Countries

China

Contacts

Public ContactXianbo Wu
10250491@qq.com15528084626

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026